SyncroMD

SyncroMD

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SyncroMD is a private, service-oriented clinical research organization (CRO) site founded in 2017 and headquartered in Brasov, Romania. It functions as a dedicated site for pharmaceutical and biotech sponsors, conducting Phase I-IV clinical trials primarily in internal medicine, pediatrics, rheumatology, and pneumology. The company's model is built on providing patient-centric, high-quality site support services within the European clinical trial landscape, leveraging Romania's cost advantages and patient populations. Its success depends on securing contracts from trial sponsors and maintaining high operational and regulatory standards.

Internal MedicinePediatricsRheumatologyPneumology

Technology Platform

Operational clinical research site infrastructure, including medical facility, trained personnel, and processes for patient recruitment, trial management, and regulatory compliance. Relies on standard clinical trial management and data capture systems.

Opportunities

Capitalizing on the growing trend of pharmaceutical sponsors outsourcing clinical trials to cost-effective Central and Eastern European countries with large, treatment-naive patient populations.
Specializing in complex therapeutic areas (e.g., rheumatology) allows it to become a preferred site for niche trials.

Risk Factors

Revenue is project-based and dependent on winning competitive bids from sponsors.
Faces significant regulatory and operational risk, where any compliance failure could damage reputation.
Increasing competition from other regional sites and large global CRO networks threatens market share and margins.

Competitive Landscape

Competes with other independent clinical research sites in Romania and Eastern Europe, as well as the site networks of large global and regional Contract Research Organizations (CROs). Differentiation is based on therapeutic expertise, patient recruitment speed, data quality, and cost. The market is fragmented but consolidating.